GD2-targeted CAR T-cell therapy with IL-15 and inducible Caspase-9
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GD2-targeted CAR T-cell therapy with IL-15 and inducible Caspase-9, covering 2026-03-27 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma [Phase 1]